Bortezomib therapy for myeloma
- PMID: 14695852
Bortezomib therapy for myeloma
Comment on
-
A phase 2 study of bortezomib in relapsed, refractory myeloma.N Engl J Med. 2003 Jun 26;348(26):2609-17. doi: 10.1056/NEJMoa030288. N Engl J Med. 2003. PMID: 12826635 Clinical Trial.
Publication types
LinkOut - more resources
Other Literature Sources